Jeremiah

We're not even allowed to tell you what we settled with the SEC about, says Ramchandra.

Or why, adds Bob.

But, says Ramchandra, we got a carve-out saying we're allowed to pitch you on our new startup, Gamified Biotech Investing.

When a company is doing its FDA studies, says Bob, we pay the study participants to use wearables that report real-time temperature, heart rate, respiratory rate, blood pressure, heart rate variability, galvanic skin response, penile tumescence.

Then they get anonymized and published to a real-time dashboard integrated as part of the Robin Hood UI.

So you can see a red line representing how study participant number 48 had a coughing fit 10 seconds ago and immediately short the experimental cancer drug he's taking.

People are going to spend all their time watching a line on a graph to see if someone's had a coughing fit 15 seconds ago?

Oh, absolutely.

Or at least, they used to.

Now they'll probably get Claude Code to do it.

What about you, Kyle?

Any interesting startups you're making Claude Code work on?

Yeah, I, well, my Claude Code is working on a solution to AI sycophancy.

Hmm.

Hmm.

I didn't think AI sycophancy was a technical problem.

It's easy enough to code a non-sycophantic AI.

I thought it was more of a market problem.

People like sycophantic assistants.

That's close to right, but there are important subtleties here.